Intas Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ChrysCapital investing up to $100m in Indian eye care chain Centre for Sight

ChrysCapital investing up to $100m in Indian eye care chain Centre for Sight
dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.

Zydus cadilaIntas pharmaMahipal singh sachdevKrishna institute of medical sciencesDr agarwal health care ltdCentre for sightMahindra holdingsFoundation holdingsNew delhi headquartered centreNorth indiaGeneral atlanticHealth careQuadria capitalKrishna instituteMedical sciencesMankind pharma

ChrysCapital closes its continuation fund at $700 million

The new fund has acquired a stake in National Stock Exchange of India Ltd from ChrysCapital s Fund VI

Asia pacificIntas pharmaNational stock exchange of india ltdChryscapital fundHexaware technologies ltdBajaj auto finance ltdAxis bank ltdFunds groupBandhan bankSuzlon ltdWow skin sciencesMahindra finance ltdInfosys ltdShriram finance ltdNational stock exchangeIndia ltd

Chrys Cap, Kedaara prepare their biggest funds ever

While ChrysCapital aims to raise $2-2.2 billion for its tenth fund, Kedaara is in the market for its fourth fund of $1-1.5 billion

Manish kejriwalSrini sriniwasanPavninder singhL catterton asiaIntas pharmaAnjana sasidharanKotak alternate asset managers ltdBajaj autoAu small finance bankWow skin sciencesNational stock exchangeAxis bankBandhan bankWhile chryscapitalKedaara capitalQuest global

Bottomline: ChrysCap, SWFs-backed Intas Pharma facing headwinds

Gujarat-based drugmaker Intas Pharmaceuticals Ltd has had a nearly three-decade-long tryst with private equity investors, having raised capital from ICICI Venture way back in 1996 ..

Abu dhabiAbuz abyUnited arab emiratesIntas pharmaIntas pharmaceuticals ltdAbu dhabi investmentIntas pharmaceuticals ltdSreeja biswas

Last mainboard listing of 2023 | Innova Captab shares close 21% higher on debut

Innova Captab | The listing was far lower than analysts expectations and the grey market premium. The expected listing premium was around 25 percent over the issue price.

Glenmark pharmaManoj kumar lohariwalaIntas pharmaAjanta pharmaEmcure pharmaceuticalsInnova captabVinay kumar lohariwala promotedMedley pharmaIndoco remediesZuventus healthcareInnova captab share priceInnova captab stock priceInnova captab price bseInnova captab nse